While co-inhibitory molecule expression was also significantly increased on CD8+ T cell populations compared to at pre-injection, the relative frequencies were lower than CD4+ T cells, which may be due to increased turnover of activated and highly tumour-reactive CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.